control of pain after surgical debridement of burn wounds

gabapentin for pain control after surgical debridement of burn wounds

Control of Pain After Surgical Debridement of Burn Wounds

We read with interest your article on the use of gabapentin pain control after burn debridement (1). Gabapentin has a well-established role in the management of neuropathic pain, and has been investigated in the past decade regarding its ability to potentiate the effect of morphine on postoperative pain, or decrease the amount of pain experienced by patients after surgery. This study represents...

Gabapentin for Pain Control After Surgical Debridement of Burn Wounds

I read with great interest the contribution “Effect of Gabapentin on Morphine Consumption and Pain after Surgical Debridement of Burn Wounds: A Double-Blind Randomized Clinical Trial Study” by Raziet al. (1). Carrying out a Randomized Controlled Trial without funding and especially in our region is an uphill task indeed. I must therefore congratulate the authors on this achievement. The trial h...

Debridement for surgical wounds.

BACKGROUND Surgical wounds that become infected are often debrided because clinicians believe that removal of this necrotic or infected tissue will expedite wound healing. There are numerous methods available but no consensus on which one is most effective for surgical wounds. OBJECTIVES To determine the effect of different methods of debridement on the rate of debridement and healing of surg...

Gabapentin for Pain Control in Burn Patients for Surgical Debridement: Pharmacokinetic Properties Consideration

c 2012, Kashan University of Medical Sciences; Published by Kowsar This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Please cite this paper as: Lui TH, Lam CS. Gabapentin for...

gabapentin for pain control in burn patients for surgical debridement: pharmacokinetic properties consideration